HSP90AB1 and breast carcinoma: We revealed that up-regulated HSP90 was significantly associated with risk of death from breast cancer among patients with HER2-/ER+ breast cancer, and greatly increased the chance of disease recurrence in TNBC, and these interactions were independent of clinical variables.